Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Grob T, Al Hinai ASA, Sanders MA, Kavelaars FG, Rijken M, Gradowska PL, Biemond BJ, Breems DA, Maertens J, van Marwijk Kooy M, Pabst T, de Weerdt O, Ossenkoppele GJ, van de Loosdrecht AA, Huls GA, Cornelissen JJ, Beverloo HB, Löwenberg B, Jongen-Lavrencic M, Valk PJM.
Grob T, et al. Among authors: ossenkoppele gj.
Blood. 2022 Apr 14;139(15):2347-2354. doi: 10.1182/blood.2021014472.
Blood. 2022.
PMID: 35108372
Free PMC article.